A New Gold Standard? Impact of Broad-spectrum Penicillin-based Antibiotic Prophylaxis on Outcome After Pancreatoduodenectomy - Results of a Systematic Review and Meta-analysis (PROSPERO CRD42024559197).

IF 7.5 1区 医学 Q1 SURGERY
Julian C Harnoss, Darius Halm, Sophie Weber, Benedict Kinny-Köster, Max Heckler, Rosa Klotz, Eva Kalkum, Jonathan M Harnoss, Julian Musa, Pascal Probst, Christoph W Michalski, Martin Loos, Thomas Hank
{"title":"A New Gold Standard? Impact of Broad-spectrum Penicillin-based Antibiotic Prophylaxis on Outcome After Pancreatoduodenectomy - Results of a Systematic Review and Meta-analysis (PROSPERO CRD42024559197).","authors":"Julian C Harnoss, Darius Halm, Sophie Weber, Benedict Kinny-Köster, Max Heckler, Rosa Klotz, Eva Kalkum, Jonathan M Harnoss, Julian Musa, Pascal Probst, Christoph W Michalski, Martin Loos, Thomas Hank","doi":"10.1097/SLA.0000000000006703","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>This review evaluated whether broad-spectrum penicillin-based antibiotic prophylaxis (BS-AB) such as piperacillin-tazobactam might lead to better outcomes in pancreatoduodenectomy compared to standard care antibiotics, mainly cephalosporins (CE-AB).</p><p><strong>Background: </strong>Pancreatoduodenectomy is commonly associated with high postoperative infectious complications contributing to increased morbidity, mortality and healthcare costs.</p><p><strong>Methods: </strong>A systemic literature search (PubMed, EMBASE, Cochrane Library and Web of Science) was conducted to identify suitable RCTs and non-RCTs. After inclusion, the data were analyzed using a random-effects model with the Mantel-Haenszel model or inverse variance to calculate, odds ratio (OR) or mean difference (MD) with 95% confidence intervals (CI).</p><p><strong>Results: </strong>One RCT and 11 non-RCTs were included with 12,469 patients (35,3% BS-AB, 64,7% CE-AB). Surgical site infections (SSI) were significantly lower after BS-AB when compared to CE-AB, (OR 0.53; CI [0.32-0.86]; P =0.01; I 2 =79%) as well as the occurrence of postoperative pancreatic fistula (POPF) (OR 0.62; CI [0.47-0.81]; P <0.01; I 2 =0%), days of hospitalization (MD-2.02; CI [-4.08-0.03]; P =0.05; I 2 =98%) and mortality (OR 0.56; CI [0.34-0.95]; P =0.03; I 2 =0%). Subgroup analyses of patients with preoperative biliary drainage demonstrated an even higher effect of BS-AB in reducing SSI (OR 0.45, CI [0.45-0.67]; P =0.01; I 2 =78%), POPF (OR 0.52; CI [0.36-0.75]; P <0.01; I 2 =0%) and mortality (OR 0.34; CI [0.15-0.76]; P <0.01; I 2 =0%).</p><p><strong>Conclusion: </strong>BS-AB significantly reduces the risk of infectious complications and surgical outcomes in pancreatoduodenectomy compared to CE-AB, particularly in patients with preoperative biliary drainage. These findings support the use of BS-AB as a new gold standard for patients undergoing pancreatoduodenectomy.</p>","PeriodicalId":8017,"journal":{"name":"Annals of surgery","volume":" ","pages":""},"PeriodicalIF":7.5000,"publicationDate":"2025-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/SLA.0000000000006703","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: This review evaluated whether broad-spectrum penicillin-based antibiotic prophylaxis (BS-AB) such as piperacillin-tazobactam might lead to better outcomes in pancreatoduodenectomy compared to standard care antibiotics, mainly cephalosporins (CE-AB).

Background: Pancreatoduodenectomy is commonly associated with high postoperative infectious complications contributing to increased morbidity, mortality and healthcare costs.

Methods: A systemic literature search (PubMed, EMBASE, Cochrane Library and Web of Science) was conducted to identify suitable RCTs and non-RCTs. After inclusion, the data were analyzed using a random-effects model with the Mantel-Haenszel model or inverse variance to calculate, odds ratio (OR) or mean difference (MD) with 95% confidence intervals (CI).

Results: One RCT and 11 non-RCTs were included with 12,469 patients (35,3% BS-AB, 64,7% CE-AB). Surgical site infections (SSI) were significantly lower after BS-AB when compared to CE-AB, (OR 0.53; CI [0.32-0.86]; P =0.01; I 2 =79%) as well as the occurrence of postoperative pancreatic fistula (POPF) (OR 0.62; CI [0.47-0.81]; P <0.01; I 2 =0%), days of hospitalization (MD-2.02; CI [-4.08-0.03]; P =0.05; I 2 =98%) and mortality (OR 0.56; CI [0.34-0.95]; P =0.03; I 2 =0%). Subgroup analyses of patients with preoperative biliary drainage demonstrated an even higher effect of BS-AB in reducing SSI (OR 0.45, CI [0.45-0.67]; P =0.01; I 2 =78%), POPF (OR 0.52; CI [0.36-0.75]; P <0.01; I 2 =0%) and mortality (OR 0.34; CI [0.15-0.76]; P <0.01; I 2 =0%).

Conclusion: BS-AB significantly reduces the risk of infectious complications and surgical outcomes in pancreatoduodenectomy compared to CE-AB, particularly in patients with preoperative biliary drainage. These findings support the use of BS-AB as a new gold standard for patients undergoing pancreatoduodenectomy.

目的:本综述评估了哌拉西林-他唑巴坦等广谱青霉素类抗生素预防性治疗(BS-AB)与标准治疗抗生素(主要是头孢菌素类)(CE-AB)相比,是否能为胰腺十二指肠切除术带来更好的治疗效果:背景:胰十二指肠切除术通常伴有较高的术后感染并发症,导致发病率、死亡率和医疗成本增加:方法:对文献进行系统检索(PubMed、EMBASE、Cochrane Library 和 Web of Science),以确定合适的 RCT 和非 RCT。纳入后,使用随机效应模型与曼特尔-海恩泽尔模型或反方差对数据进行分析,计算出几率比(OR)或平均差(MD)以及 95% 的置信区间(CI):结果:共纳入 1 项 RCT 和 11 项非 RCT,12469 名患者(35.3% 为 BS-AB,64.7% 为 CE-AB)。与CE-AB相比,BS-AB术后手术部位感染(SSI)明显降低(OR 0.53;CI [0.32-0.86];P =0.01;I 2 =79%),术后胰瘘(POPF)的发生率也明显降低(OR 0.62;CI [0.47-0.81];P 结论:BS-AB可显著降低术后胰瘘的发生率:与 CE-AB 相比,BS-AB 能明显降低胰十二指肠切除术中感染并发症的风险和手术效果,尤其是术前有胆道引流的患者。这些研究结果支持将 BS-AB 作为胰十二指肠切除术患者的新金标准。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Annals of surgery
Annals of surgery 医学-外科
CiteScore
14.40
自引率
4.40%
发文量
687
审稿时长
4 months
期刊介绍: The Annals of Surgery is a renowned surgery journal, recognized globally for its extensive scholarly references. It serves as a valuable resource for the international medical community by disseminating knowledge regarding important developments in surgical science and practice. Surgeons regularly turn to the Annals of Surgery to stay updated on innovative practices and techniques. The journal also offers special editorial features such as "Advances in Surgical Technique," offering timely coverage of ongoing clinical issues. Additionally, the journal publishes monthly review articles that address the latest concerns in surgical practice.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信